Routine provision of nevirapine to women of unknown serostatus: at best a temporary solution to prevent MTCT
Saved in:
Main Author: | Marie-Louise Newell (Author) |
---|---|
Format: | Book |
Published: |
The World Health Organization,
2005-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Should nevirapine be used to prevent mother-to-child transmission of HIV among women of unknown serostatus?
by: Tin Tin Sint, et al. -
Determinants of HIV serostatus disclosure and assessment of the competence of health care personnel in HIV serostatus disclosure
by: Adekunle MO, et al.
Published: (2019) -
Pregnant women's knowledge about Mother-to-Child Transmission (MTCT) of HIV infection through breast feeding
by: MS Maputle
Published: (2008) -
Breaking the ice: HIV serostatus disclosure
by: Deepak Asudani, et al.
Published: (2004) -
Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda
by: Placidie Mugwaneza, et al.
Published: (2018)